Market Cap | 3.74M | P/E | - | EPS this Y | 57.30% | Ern Qtrly Grth | - |
Income | -6.48M | Forward P/E | -1.03 | EPS next Y | - | 50D Avg Chg | -7.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -48.00% |
Dividend | N/A | Price/Book | 3.77 | EPS next 5Y | - | 52W High Chg | -89.00% |
Recommedations | 2.00 | Quick Ratio | 0.12 | Shares Outstanding | 1.15M | 52W Low Chg | 13.00% |
Insider Own | 17.36% | ROA | -30.08% | Shares Float | 0.99M | Beta | 0.27 |
Inst Own | 5.76% | ROE | -332.19% | Shares Shorted/Prior | 173.59K/56.87K | Price | 0.11 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 1,829,330 | Target Price | 8.00 |
Oper. Margin | - | Earnings Date | May 7 | Volume | 942,726 | Change | -1.31% |
IMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.